Healthcare - Biotechnology - NASDAQ - DK
$ 1.44
-14.3 %
$ 8.16 M
Market Cap
-0.51
P/E
BALANCE SHEET
12.9 M
ASSETS
17.6 M
LIABILITIES
-4.73 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Evaxion Biotech A/S
| Current Assets | 8.35 M |
| Cash & Short-Term Investments | 5.58 M |
| Receivables | 1.07 M |
| Other Current Assets | 1.69 M |
| Non-Current Assets | 4.54 M |
| Long-Term Investments | 29 K |
| PP&E | 4.34 M |
| Other Non-Current Assets | 167 K |
| Current Liabilities | 7.08 M |
| Accounts Payable | 2.69 M |
| Short-Term Debt | 485 K |
| Other Current Liabilities | 3.91 M |
| Non-Current Liabilities | 10.5 M |
| Long-Term Debt | 10.4 M |
| Other Non-Current Liabilities | 159 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 5.6 | 13.2 | 32.2 | 5.8 | 9.6 | 7.4 | 0.5 |
| Short Term Investments | 165 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.1 | 0 | 0 | 0 | 0.9 | 0.8 | 2.1 |
| Inventory | 0 | (2.5) | (1.9) | (6.9) | 6 | (1.4) | 0 |
| Other Current Assets | 1.7 | 2.5 | 3.2 | 6.3 | 0.5 | 0.2 | 0.1 |
| Total Current Assets | 8.3 | 14.0 | 34.7 | 5.8 | 11.0 | 8.4 | 2.7 |
| PP&E | 4.3 | 4.7 | 5.4 | 0.5 | 0.1 | 0.1 | 0.2 |
| Intangible Assets | 0 | 0 | 93 K | 100 K | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 29 K | 0.2 | 0 | 5.3 | 0 | 0 | 0 |
| Other Long Term Assets | 0.2 | 0.2 | 0 | 2 K | 0 | 0 | 2 K |
| Other Assets | 134 | (78.0) | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 12.9 | (58.9) | 40.2 | 12.0 | 11.1 | 8.5 | 2.9 |
| LIABILITIES | |||||||
| Accounts Payable | 2.7 | 2.1 | 2.8 | 3.7 | 0.6 | 0.1 | 59 K |
| Short Term Debt | 0.5 | 0.4 | 0.4 | 40 K | 36 K | 8.6 | 66 K |
| Other Current Liabilities | 3.9 | 1.2 | 1.0 | 1.2 | 1.0 | 0.6 | 0.2 |
| Total Current Liabilities | 7.1 | 3.8 | 4.3 | 4.9 | 1.7 | 9.4 | 0.3 |
| Long Term Debt | 10.4 | 3.9 | 3.2 | 0 | 0 | 24 K | 96 K |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.2 | 6.1 | 0.2 | 0 | 0 | 0 | 0 |
| Total Liabilities | 17.6 | 13.7 | 7.7 | 4.9 | 1.7 | 9.4 | 0.4 |
| EQUITY | |||||||
| Common Stock | 5.9 | 3.9 | 3.8 | 2.6 | 2.5 | 2.1 | 2.1 |
| Retained Earnings | (108.0) | (72.7) | (50.4) | (27.3) | (15.8) | (7.0) | (3.5) |
| Other Accumulative Comprehensive Income/Loss | (3.8) | (3.7) | 79.1 | 31.7 | 22.7 | 3.9 | 4.0 |
| Total Equity | (4.7) | (72.7) | (50.4) | 7.0 | 9.4 | (0.9) | 2.5 |
| Total Liabilities and Equity | 12.9 | (58.9) | (42.7) | 12.0 | 11.1 | 8.5 | 2.9 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 2.7 | 2.4 | 1.9 | 1.6 | 1.6 | 1.9 |